Article Text

PDF
Incidence of extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasms of the pancreas
  1. Kazumichi Kawakubo,
  2. Minoru Tada,
  3. Hiroyuki Isayama,
  4. Naoki Sasahira,
  5. Yousuke Nakai,
  6. Keisuke Yamamoto,
  7. Hirofumi Kogure,
  8. Takashi Sasaki,
  9. Kenji Hirano,
  10. Hideaki Ijichi,
  11. Keisuke Tateishi,
  12. Haruhiko Yoshida,
  13. Kazuhiko Koike
  1. Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  1. Correspondence to Minoru Tada, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; mtada-tky{at}umin.ac.jp

Abstract

Background and aims Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas have been reported to be associated with extrapancreatic malignancies, but there have been no prospective studies evaluating the incidence of extrapancreatic cancers in patients with IPMNs. In this study, the frequency of patients with IPMNs developing extrapancreatic cancers during follow-up was examined.

Methods 642 patients with IPMNs were prospectively followed up for 4.8 years on average. They underwent clinical examination at least twice a year. The incidence of the observed extrapancreatic malignancies was compared with the expected incidence of the age- and gender-matched general Japanese population based on the Vital Statistics of Japan.

Results 40 extrapancreatic cancers developed in 39 patients during follow-up (1.3% per year). The most common malignancies were hepatocellular (n=7), colorectal (n=6), gastric (n=6), lung (n=5) and prostate cancers (n=4). The calculated standardised incidence rate of each of the malignancies was not significant, as follows: hepatocellular 2.17 (95% CI 0.87 to 4.47), colorectal 1.02 (0.37 to 2.21), gastric 0.76 (0.28 to 1.66), lung 0.75 (0.24 to 1.76) and prostate 1.00 (0.71 to 1.29). Pancreatic cancer was observed in 17 patients during the same period, with a standardised incidence rate of 10.7 (6.2 to 17.1).

Conclusions The incidence of extrapancreatic malignancies in patients with IPMNs was similar to that in the general population, whereas the incidence of pancreatic cancers was significantly high. Intraductal papillary mucinous neoplasms are not associated with systemic carcinogenesis except for pancreatic cancer.

  • Intraductal papillary mucinous neoplasm
  • standardised incidence rate
  • extrapancreatic malignancy
  • carcinogenesis
  • pancreatic disease
  • pancreatic epidemiology

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.